Career Journeys of Executive Women Leaders – Hosted by EWIB Connecticut

Join Executive Women In Bio Connecticut as three dynamic women executives with varying career paths share their success stories and valuable learnings that helped them along the way. Don’t miss this opportunity to gain critical insights and advice that will enable the achievement of your career objectives and propel the journey that is right for you!

Program:

12:00 p.m. – 12:05 p.m.  Check-in
12:05 p.m. – 12:10 p.m.  Introductions
12:10 p.m. – 12:50 p.m.  Programming
12:50 p.m. – 1:00 p.m.  Q&A

Speaker Bios:

Ellen Brett, Partner at HawkPartners

Ellen joined HawkPartners in 2023 as a Partner and Growth Strategy Expert to propel the firm’s capability to illuminate opportunity and create paths to capture it with confidence. Ellen is a 30-year veteran of the life sciences industry and a pioneer of patient-centered methodologies. During a prestigious 18-year career at Pfizer, she led strategies for several of the most significant brands in the industry, including Zyrtec®, Chantix®, Viagra®, Lipitor®, and Lyrica®. Ellen’s breakthrough results propelled her to the firm’s most senior marketing leadership position. Ellen also served as the Primary Care Group’s head of Global Strategy and Innovation. Prior to joining HawkPartners, Ellen formed Brett Innovation, a boutique consultancy specializing in growth strategies for value-based healthcare. Ellen developed and trademarked her signature Triple Lens® approach for assessment of the market and finding growth opportunities that provide value to patients, the healthcare system, and the firm. Ellen received a BS in materials science engineering from Cornell University and an MBA from Columbia Business School.

Camille Hertzka, VP, Global Franchise Head, Oncology R&D at AstraZeneca

Camille Hertzka is responsible for the strategy and execution of the DDR late-stage portfolio at AstraZeneca (AZ). Camille is a scientist by training and has 18 years of industry experience in oncology in both medical affairs and R&D. At AZ, she has been the Head of Europe and then of the international region for oncology medical, aiming to bring medicines for patients across the globe affected by various tumor types. She has also been responsible for the life cycle management and overall strategy of Olaparib in GYN cancers as a Global Product Lead before joining the US Medical team as VP Head of USMA. Prior to AZ, Camille worked at Bristol-Myers Squibb, mainly leading medical affairs activities in melanoma and GU cancers for the European region, and at Roche in France, mainly focused on bringing innovative medicines to patients with lung cancer, brain tumors, and GU cancers. Camille is a passionate leader, focused on addressing the needs of all patients with cancers.

Christelle Huguet, EVP, R&D at Ipsen

Christelle was appointed Executive Vice President, R&D at Ipsen in September 2023. Christelle is responsible for the discovery of late-stage development programs across our three therapeutic areas of oncology, rare disease, and neuroscience, in addition to leading Ipsen’s external innovation strategy. Christelle joined Ipsen in May 2020 as Head of Research, External Innovation, and Early Development, where she drove the expansion of early development and clinical portfolio in addition to overseeing all early development programs to accelerate innovation. Previously, Christelle served as Chief Scientific Officer of X-Chem, moving from Alexion Pharmaceuticals, where she was Head of Internal Research focusing on rare diseases. Prior to this, Christelle held a variety of leadership roles at Pfizer, specializing in drug discovery and development across multiple therapeutic areas, including immunology and inflammation, respiratory, women’s health, and gastrointestinal. Christelle received a PhD in molecular and cellular biology at the Pasteur Institute.